Analysts Comment On Intercept Amid Share Decline Following FLINT Data Delay

By: via Benzinga
Shares of Intercept Pharmaceuticals (NASDAQ: ICPT) have dropped over four percent on the FLINT data delay. On Wednesday, Chief ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.